Ikarian Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Ikarian Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,561	Closed	-$110K	–	215
2022 Q1	$110K	Buy	15,561 +748	+5%	+$7.33K	0.01%	180
2021 Q4	$195K	Hold	14,813	–	–	0.03%	158
2021 Q3	$341K	Sell	14,813 -187	-1%	-$5.56K	0.02%	194
2021 Q2	$659K	Sell	15,000 -10,000	-40%	-$557K	0.05%	176
2021 Q1	$1.81M	Buy	+25,000	New	+$1.78M	0.06%	209

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ikarian Capital's ORTX Position: Q2 2022 in Review

Ikarian Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 15,561 shares — an estimated $110K sold.

Ikarian Capital first reported a position in ORTX in Q1 2021 and held it in 5 quarters. The position peaked at $1.81M in Q1 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

Ikarian Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Ikarian Capital sold 15,561 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $110K.
Ikarian Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 5 quarters.
Ikarian Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $1.81M in Q1 2021.
50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.